Report of the skin research workgroups from the GRAPPA 2018 annual meeting

Lourdes M. Perez-Chada, Joseph F. Merola, April W. Armstrong, Alice B. Gottlieb

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

At the 2018 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the International Dermatology Outcome Measures (IDEOM) Psoriasis Working Group presented an overview of its efforts to enhance clinical care and research in both the clinical setting as well as in clinical trials for psoriasis. First, the group discussed the results of a Delphi survey conducted in collaboration with the American Academy of Dermatology to agree on a unique physician-reported global assessment to measure the quality of care delivered to patients with psoriasis and other chronic inflammatory dermatoses. Second, the group summarized its efforts to select outcome measures for "PsA symptoms"and "treatment satisfaction,"2 of the domains of the psoriasis core domain set that were established by IDEOM. Finally, the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network (PPACMAN) presented an update on its clinical, educational, and research missions to foster the development of combined clinics for psoriatic disease, increase disease awareness, and accelerate management.

Original languageEnglish
Pages (from-to)28-32
Number of pages5
JournalJournal of Rheumatology
Volume95
DOIs
StatePublished - 1 Jun 2018

Keywords

  • GRAPPA
  • IDEOM
  • Psoriasis
  • Psoriasis Outcomes
  • Psoriatic Arthritis
  • Treatment Satisfaction

Fingerprint

Dive into the research topics of 'Report of the skin research workgroups from the GRAPPA 2018 annual meeting'. Together they form a unique fingerprint.

Cite this